IP Library Granted Patent US 12,201,470
Granted Patent B2
US 12,201,470 · App. 17/076,384 · Granted Jan 21, 2025

System and method for feature extraction and classification on ultrasound tomography images

Inventors: Majid Mahrooghy (Novi, MI); Gursharan Singh Sandhu (Novi, MI); Peter Littrup (Novi, MI)
Assignee: Delphinus Medical Technologies, Inc.
A61B8/08A61B8/0825A61B8/085A61B8/5223G06T7/0012G06V10/25G06V10/26G06V10/44G06V10/764G06V10/7715G06V10/82G06T2207/10132G06T2207/20081G06T2207/30096
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,201,470
App. No.
17/076,384
Granted
Jan 21, 2025
Kind
B2
Abstract

Disclosed herein systems, processors, or computer-readable media configured with instructions to: receive transmission and/or reflection images of a tissue of a subject, wherein the images are generated from acoustic signals derived from acoustic waveforms transmitted through the tissue; provide a set of prognostic parameters associated with a user selected region of interest; wherein the set of prognostic parameters comprises sound propagation metrics characterizing sound propagation within a tissue; wherein the set of prognostic parameters corresponds to inputs into a tissue classifier model; wherein the set of prognostic parameters comprises a plurality of subsets of related feature groupings; and determine a type of tissue of the subject based on said plurality of subsets of related feature groupings using the classifier model, wherein the type of tissue is a cancerous tumor, a fibroadenoma, a cyst, a nonspecific benign mass, and an unidentifiable mass.

Claims (28)

1. A computer implemented method for characterizing a lesion in a volume of tissue, the method comprising:

receiving a plurality of acoustic renderings, the acoustic renderings comprising a representation of sound propagation through the volume of tissue, wherein the plurality of acoustic renderings comprises at least a transmission rendering and a reflection rendering;

determining a set of prognostic parameters, wherein the set of prognostic parameters comprises one or a plurality of sound propagation metrics that are derived from the plurality of acoustic renderings; and

applying a classifier model to classify the volume of tissue, wherein the classifier model is generated from:

a first classifier configured to assign each prognostic parameter of a plurality of prognostic parameters a predictive value and

generate the set of prognostic parameters from the plurality of prognostic parameters based on the predictive value of each prognostic parameter of the plurality of prognostic parameters, wherein the first classifier configured to trim the plurality of prognostic parameters based on the predictive value to generate the set of prognostic parameters; and

a second classifier configured to calculate a score relating to a probability that the lesion is of a classification based on the set of prognostic parameters, wherein said second classifier is a trained classifier trained at least in part on the set of prognostic parameters and a plurality of classified acoustic renderings.

2. The method of claim 1 , wherein the lesion comprises a cancer, a fibroadenoma, a cyst, a nonspecific benign mass, or an unidentifiable mass.

3. The method of claim 1 , wherein the plurality of acoustic renderings comprises one or more of: (i) a plurality of reflection renderings, (ii) a plurality of transmission renderings, or (iii) at least one reflection rendering and at least one transmission rendering.

4. The method of claim 1 , wherein the transmission rendering comprises a sound speed rendering or an attenuation rendering.

5. The method of claim 1 , wherein the plurality of prognostic parameters comprises sound speed metrics relating to a region of interest and (i) is based on the region of interest or (ii) comprises a user-assigned classification of the region of interest.

6. The method of claim 5 , wherein the region of interest (i) is a user selected region of interest, (ii) is partially selected using the set of prognostic parameters, (iii) comprises a portion of a lesion, or (iv) comprises a two-dimensional region of interest.

7. The method of claim 6 , wherein the two-dimensional region of interest is used to generate a three-dimensional region of interest.

8. The method of claim 5 , wherein the user-assigned classification is a mass boundary score.

9. The method of claim 1 , wherein the set of prognostic parameters comprises at least one member selected from the group consisting of: a morphological metric of the lesion, crispiness, a texture metric of the region of interest, and fuzziness.

10. The method of claim 9 , wherein the morphological metric comprises:

(i) at least one of a roundness, an irregularity of a shape, an irregularity of a margin, and a smoothness of a margin;

(ii) the fuzziness of a boundary of the lesion; or

(iii) the crispiness of a margin of the lesion.

11. The method of claim 1 , wherein the one or a plurality of sound propagation metrics characterizes one or more of: (i) sound propagation interior to a region of interest or (ii) sound propagation exterior to a region of interest.

12. The method of claim 1 , wherein the one or the plurality of sound propagation metrics comprises at least one of a mean, a standard deviation, a skewness, and a kurtosis.

13. The method of claim 1 , wherein the one or the plurality of sound propagation metrics characterizes at least one of sound speed, sound attenuation, and sound reflection.

14. The method of claim 1 , wherein the one or the plurality of sound propagation metrics comprises one or more members selected from the group consisting of a sound speed metric, a reflection metric, an attenuation metric, a morphological metric, and a user defined score.

15. The method of claim 1 , wherein the set of prognostic parameters comprises one or more of: (i) one or a plurality of sound propagation metrics characterizing sound speed, (ii) one or a plurality of sound propagation metrics characterizing sound attenuation, or (iii) one or a plurality of sound propagation metrics characterizing sound reflection.

16. The method of claim 1 , wherein the classifier model determines a type of tissue with a sensitivity at least 85% and a specificity of at least 84%.

17. The method of claim 1 , wherein the classifier model determines: (i) a threshold value of one or more prognostic parameters sufficient to classify a tissue, (ii) a relative statistical accuracy of one or more prognostic parameters, (iii) a threshold value of the set of prognostic parameters sufficient to classify a tissue, or a combination thereof.

18. The method of claim 1 , wherein the classifier determines a likelihood that the lesion is a malignant lesion.

19. The method of claim 1 , wherein the trained classifier is generated using a machine learning technique.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2025
From: DELPHINUS MEDICAL TECHNOLOGIES, INC.
To: APERIA MEDICAL, LLC
Reel/Frame 072495/0454 →
RELEASE OF SECURITY INTEREST Recorded Mar 11, 2024
From: TRINITY CAPITAL INC.
To: DELPHINUS MEDICAL TECHNOLOGIES, INC.
Reel/Frame 066782/0168 →
SECURITY INTEREST Recorded Jun 26, 2023
From: DELPHINUS MEDICAL TECHNOLOGIES, INC.
To: TRINITY CAPITAL INC.
Reel/Frame 064093/0550 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2021
From: MAHROOGHY, MAJID; SANDHU, GURSHARAN SINGH; LITTRUP, PETER
To: DELPHINUS MEDICAL TECHNOLOGIES, INC.
Reel/Frame 055407/0286 →
Continuity (4)
Continuation PCTUS2019029592 · Apr 29, 2019
Provisional Application 62838174 · Apr 24, 2019
Provisional Application 62664038 · Apr 27, 2018
Related Publication 20210035296A1 · Feb 4, 2021
References Cited (55)
US 8663113B2 · Schmidt et al. · 2014 [cited by applicant]
US 9113835B2 · Li · 2015 [cited by applicant]
US 9763641B2 · West et al. · 2017 [cited by applicant]
US 10076304B2 · Tesic et al. · 2018 [cited by applicant]
US 10123770B2 · Szpak et al. · 2018 [cited by applicant]
US 10143443B2 · Duric et al. · 2018 [cited by applicant]
US 10285667B2 · Duric et al. · 2019 [cited by applicant]
US 10368831B2 · Duric et al. · 2019 [cited by applicant]
US 10743837B2 · Sandhu et al. · 2020 [cited by applicant]
US 11350905B2 · Duric et al. · 2022 [cited by applicant]
US 20030007598A1 · Wang · 2003 [cited by examiner]
US 20090016586A1 · Gardner et al. · 2009 [cited by applicant]
US 20110201932A1 · Duric et al. · 2011 [cited by applicant]
US 20120243757A1 · Funka-Lea et al. · 2012 [cited by applicant]
US 20130204136A1 · Duric et al. · 2013 [cited by applicant]
US 20130204137A1 · Roy et al. · 2013 [cited by applicant]
US 20130251222A1 · Huang · 2013 [cited by applicant]
US 20130315465A1 · Cosatto et al. · 2013 [cited by applicant]
US 20140018682A1 · Baba et al. · 2014 [cited by applicant]
US 20150025388A1 · Huang et al. · 2015 [cited by applicant]
US 20150297173A1 · Klock et al. · 2015 [cited by applicant]
US 20150297174A1 · Duric · 2015 [cited by examiner]
US 20160038123A1 · Duric et al. · 2016 [cited by applicant]
US 20160317121A1 · Frenz et al. · 2016 [cited by applicant]
US 20170337687A1 · Wang et al. · 2017 [cited by applicant]
US 20200022672A1 · Duric et al. · 2020 [cited by applicant]
US 20210390701A1 · Fan · 2021 [cited by examiner]
CN 105377145A · 2016 [cited by applicant]
CN 106778829 · 2019 [cited by examiner]
EP 2533684A1 · 2012 [cited by applicant]
JP 2003116855A · 2003 [cited by applicant]
JP 2008541889A · 2008 [cited by applicant]
JP 2012239546A · 2012 [cited by applicant]
JP 2013519455 · 2013 [cited by examiner]
JP 2013519455A · 2013 [cited by applicant]
JP 2013244218A · 2013 [cited by applicant]
JP 2015154918A · 2015 [cited by applicant]
JP 6468179 · 2019 [cited by examiner]
WO WO2017040866A1 · 2017 [cited by applicant]
WO WO2017139389A1 · 2017 [cited by applicant]
WO WO2017079843 · 2018 [cited by examiner]
WO WO2018102776 · 2018 [cited by applicant]
WO WO2019210292A1 · 2019 [cited by applicant]
EP19792932.6 Extended Search Report dated Nov. 26, 2021. [cited by applicant]
U.S. Appl. No. 16/443,993 Notice of Allowance dated Feb. 2, 2022. [cited by applicant]
U.S. Appl. No. 16/443,993 Office Action dated Jul. 8, 2021. [cited by applicant]
Cosman, Pamela. Gray-Level Co-occurrence Matrices (GLCMs). Available at http://www.code.ucsd.edu/pcosman/glcm.pdf ; Accessed on Jan. 19, 2021. [cited by applicant]
Duric et al. Breast imaging with ultrasound tomography: clinical results at the karmanos cancer institute; Biomedical Engineering and Informatics, 2008; IEEE International Conference, pp. 713-717 (2008). [cited by applicant]
Duric et al., In-vivo imaging of breast cancer with ultrasound tomography: probing the tumor environment, Medical Imaging 2011: Ultrasonic Imaging, Tomography, and Therapy, vol. 7968, No. 1, pp. 1-7 (2011). [cited by applicant]
EP17876240.7 European Search Report dated Jun. 4, 2020. [cited by applicant]
Honda, et al., Computer-Aided Diagnosis Scheme for Distinguishing Between Benign and Malignant Masses in Breast DCE-MRI. J Digit Imaging. Jun. 2016; 29(3): 388-393. [cited by applicant]
PCT/US2017/064350 International Search Report and Written Opinion dated Mar. 22, 2018. [cited by applicant]
PCT/US2019/029592 International Search Report & Written Opinion dated Sep. 11, 2019. [cited by applicant]
U.S. Appl. No. 15/829,748 Office Action dated Oct. 1, 2018. [cited by applicant]
U.S. Appl. No. 15/829,748 Notice of Allowance dated Mar. 20, 2019. [cited by applicant]